Doustdar said Medicare coverage and the launch of Novo’s new obesity pill should help gradually boost prescription volumes and offset lower prices in the U.S.
Doustdar said Medicare coverage and the launch of Novo’s new obesity pill should help gradually boost prescription volumes and offset lower prices in the U.S.